Therapeutic Asset Ratings
2,003 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
cc-5013
Post-transplant MRD-guided Maintenance Therapy
M.D. Anderson Cancer Center
P2
CCC
(53)
cc-5013
Disease Related To Transplantation
M.D. Anderson Cancer Center
P2
CCC
(53)
cc-5013
SMARCB1 Negative
M.D. Anderson Cancer Center
P2
CCC
(53)
Cedazuridine
Acute Biphenotypic Leukemia
M.D. Anderson Cancer Center
P2
CCC
(53)
Cediranib
Appendix Adenocarcinoma
M.D. Anderson Cancer Center
P2
CCC
(53)
Cediranib
ATM Gene Mutation
M.D. Anderson Cancer Center
P2
CCC
(53)
Cediranib
BRCA1 Gene Mutation
M.D. Anderson Cancer Center
P2
CCC
(53)
Cediranib
BRCA1-Related Cancer Predisposition
M.D. Anderson Cancer Center
P2
CCC
(53)
Cediranib
BRCA2-Related Cancer Predisposition
M.D. Anderson Cancer Center
P2
CCC
(53)
Cediranib
Human Papillomavirus-Related Anal Squamous Cell Carcinoma
M.D. Anderson Cancer Center
P2
CCC
(53)
Cediranib
Human Papillomavirus-Related Squamous Cell Carcinoma of the Penis
M.D. Anderson Cancer Center
P2
CCC
(53)
Cediranib
Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma
M.D. Anderson Cancer Center
P2
CCC
(53)
Cediranib
Neuroendocrine Carcinoma
M.D. Anderson Cancer Center
P2
CCC
(53)
Cediranib
PALB2 Gene Mutation
M.D. Anderson Cancer Center
P2
CCC
(53)
Cediranib
Recurrent Nasopharynx Carcinoma
M.D. Anderson Cancer Center
P2
CCC
(53)
Cediranib
Recurrent Peritoneal Malignant Mesothelioma
M.D. Anderson Cancer Center
P2
CCC
(53)
Cediranib
Recurrent Pleural Malignant Mesothelioma
M.D. Anderson Cancer Center
P2
CCC
(53)
Cediranib
Vaginal Squamous Cell Carcinoma, Not Otherwise Specified
M.D. Anderson Cancer Center
P2
CCC
(53)
Ceralasertib
BRCA1-Related Cancer Predisposition
M.D. Anderson Cancer Center
P2
CCC
(53)
Ceralasertib
BRCA2-Related Cancer Predisposition
M.D. Anderson Cancer Center
P2
CCC
(53)
Ceralasertib
Her2-Receptor Negative Breast Cancer
M.D. Anderson Cancer Center
P2
CCC
(53)
Ceralasertib
Fallopian Tube Carcinoma
M.D. Anderson Cancer Center
P2
CCC
(53)
Ceralasertib
Ovarian Carcinoma
M.D. Anderson Cancer Center
P2
CCC
(53)
Ceralasertib
Primary Peritoneal Carcinoma
M.D. Anderson Cancer Center
P2
CCC
(53)
Cetrelimab
Prostate Carcinoma
M.D. Anderson Cancer Center
P2
CCC
(53)
Showing 601 to 625 of 2,003 assets
Previous
Page 25 of 81
Next